| AEGSX | EGINX | AEGSX / EGINX | |
| Total Expense Ratio | 0.86 | 1.00 | 86% |
| Annual Report Gross Expense Ratio | 0.97 | 1.25 | 78% |
| Fund Existence | 9 years | 23 years | - |
| Gain YTD | 19.352 | 19.195 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 950M | 950M | 100% |
| Annual Yield % from dividends | 2.12 | 1.77 | 120% |
| Returns for 1 year | 17.20 | 16.97 | 101% |
| Returns for 3 years | 26.93 | 25.96 | 104% |
| Returns for 5 years | -2.19 | -3.54 | 62% |
| Returns for 10 years | N/A | 38.40 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GXXIX | 14.42 | 0.14 | +0.98% |
| abrdn US Sustainable Leaders InstlSvc | |||
| HSVRX | 54.68 | 0.40 | +0.74% |
| Harbor Small Cap Value Admin | |||
| TRZPX | 26.96 | -0.20 | -0.74% |
| T. Rowe Price European Stock Z | |||
| PREQX | 6.98 | -0.07 | -0.99% |
| PACE Global Real Estate Securities P | |||
| PRHSX | 89.67 | -1.08 | -1.19% |
| T. Rowe Price Health Sciences | |||